Publication date (field_publication_date)
Grantee News · May 27, 2021
It's the rare individual who actually looks forward to getting jabbed with a needle, even if what's in the needle can protect them from a serious disease such as COVID-19. Source: National Public Radio.
Grantee News · May 6, 2021
New research demonstrates that noninvasive neuromodulation via low-intensity ultrasound can have cell-type selectivity in manipulating neurons.
Grantee News · May 5, 2021
Chase Cornelison's research at UMass Amherst explores the proliferating power of cancer cells to treat spinal cord injuries and restore function following brain damage, promising research that has earned an NIH Trailblazer Award. Source: News Medical.
Grantee News · March 31, 2021
Researchers have generated synthetic mucins with a polymer backbone that more accurately mimics the structure and function of naturally occurring mucins. They also showed that these synthetic mucins could effectively neutralize the bacterial toxin that causes cholera.
Grantee News · March 25, 2021
Sickle cell disease is the most prevalent inherited blood disorder in the world, affecting 70,000 to 100,000 Americans. However, it is considered an orphan disease, meaning it impacts less than 200,000 people nationally, and is therefore underrepresented in therapeutic research.
Grantee News · March 17, 2021
In Made of Stronger Stuff, psychologist Kimberley Wilson and doctor Xand van Tulleken learn how Jason became the first person in the world with a neural enabled prosthetic hand, and as a result, regained the sensation of touch in his fingers. Source: BBC Radio Podcast.
Grantee News · February 16, 2021
Engineers have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol or caffeine. It is the first wearable device that monitors cardiovascular signals and multiple biochemical levels in the human body at the same time.
Grantee News · February 16, 2021
Vascular and interventional radiologists report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab. This discovery could solve a problem that has long plagued drug delivery to tumors.
Grantee News · January 25, 2021
Biomedical engineers have demonstrated that human muscle has an innate ability to ward off damaging effects of chronic inflammation when exercised. The discovery was made possible through the use of lab-grown, engineered human muscle, demonstrating the potential power of the first-of-its-kind platform in such research endeavors.